A new type of medical treatment is scheduled to travel the highways and byways from headquarters in Temple in an effort to provide treatment to cancer patients, specifically male prostate cancer ...
Manish R. Patel, MD is Oral Presenter of Abstract Analyzing Effectiveness of First-In-Human Study of Cutting-Edge Treatment For Advanced Prostate Cancer at AUA meeting Manish R. Patel, MD is Oral ...
Stage 2 prostate adenocarcinoma is localized, with a nearly 100% five-year relative survival rate. Diagnosis uses the TNM system, PSA levels, and Gleason score to determine cancer stage and risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results